Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRI vs Irinotecan in Second-line Metastatic Colorectal Cancer
NCT02935764Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Oct 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of fluorouracil in metastatic colorectal cancer (mCRC) (2 arms), sponsored by Fudan University. Primary endpoint: Progression Free Survival at 2 months. Status: unknown.
02
Drugs
fluorouracil
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02935764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02935764.